Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Photo: Win McNamee/Getty Images

The Trump administration has decided to go it alone on developing and distributing a coronavirus vaccine, after refusing to join the World Health Organization's efforts to provide equitable doses for all countries, the Washington Post reports.

Why it matters: The U.S. is betting it will win the race for a coronavirus vaccine without any help from foreign countries.

  • “The United States will continue to engage our international partners to ensure we defeat this virus, but we will not be constrained by multilateral organizations influenced by the corrupt World Health Organization and China,” said Judd Deere, a spokesperson for the White House.

State of play: 172 countries have submitted “expressions of interest” in the COVAX initiative, led by the WHO, the Coalition for Epidemic Preparedness Innovations and Gavi.

  • They hope to avoid an outcome where access to vaccines is initially limited to countries that produce them or can afford to buy them at scale.
  • The idea is that rich and middle-income countries will help fund the development of at least nine vaccine candidates. Once one of those vaccines is approved, it will be distributed globally according to need, including to poorer countries.
  • Distribution will be based on population size, with health care workers and vulnerable people prioritized and a portion kept in reserve to be deployed to hot spots.
  • The groups behind COVAX are aiming to avoid a higher-stakes repeat of the 2009 H1N1 vaccine, which was secured almost entirely by rich countries.

But the U.S. and several other rich countries or blocs — the U.K., EU, Japan — have also been spending billions of dollars to ensure their access to the leading vaccine candidates.

  • Given the limits on global manufacturing capacity, those deals could undermine the effectiveness of the global initiative.

What to watch: While countries like the U.K. and Japan have also expressed interest in the COVAX initiative, the U.S. is going it entirely alone.

  • It has purchased a combined 800 million doses of six vaccines, with the option to buy 1 billion more, per Nature.
  • The Trump administration has compared its approach to that of an airplane passenger securing their oxygen mask before helping others, Thomas Bollyky and Chad Bown write in Foreign Affairs — though they note that "airplane oxygen masks do not drop only in first class."

Yes, but: "An unlikely worst-case scenario, experts said, is that none of the U.S. vaccine candidates are viable, leaving the United States with no option since it has shunned the COVAX effort," per the Post.

Go deeper

Dec 9, 2020 - Health

Pennsylvania governor tests positive for coronavirus

Gov. Tom Wolf at a press conference on Oct. 1. Photo: Pete Bannan/MediaNews Group/Daily Local News via Getty Images

Pennsylvania Gov. Tom Wolf (D), 72, tested positive for COVID-19 on Tuesday, and is experiencing no symptoms as he self-isolates, he tweeted Wednesday.

The big picture: Current coronavirus hospitalizations and cases are skyrocketing in Pennsylvania, as well as in many states across the U.S., per the COVID Tracking Project. Wolf tweeted on Tuesday that "hospitalizations are reaching critical levels" in his state.

Cuomo: "No way I resign" after sexual harassment accusations

Cuomo at a Feb. 24 press conference. Photo: Seth Wenig/pool/AFP via Getty Images

New York Gov. Andrew Cuomo (D) was defiant on Sunday, stating again that he would not resign even as more former aides have come forward with allegations of sexual harassment and inappropriate behavior.

The big picture: Cuomo has denied all sexual harassment allegations against him and said that he "never inappropriately touched anybody." He acknowledged in a statement that "some of the things I have said have been misinterpreted as an unwanted flirtation." Some of the calls for Cuomo to resign have come from within the Democratic party.